Latest filing published 02 Mar 2023 for Abbott Laboratories, €114k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Julie L. Tyler: trading record in brief
Julie L. Tyler is a declared insider of Abbott Laboratories (senior executive), with filings sourced from SEC (Form 4). In total, 14 filings cover trades dated from 1 July 2021 to 1 March 2023.
No open-market purchase appears, only 4 sales worth €151k. Besides market trades, the filings include 10 share grants. Since January 2023: no purchases and 2 sales on the market.
On 2 March 2023 came the latest disclosure, an open-market sale for €50k in Abbott Laboratories. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Julie L. Tyler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,209 shares@ US$99.7756.5% of flowCommon shares without par valueSEC:0001415889-23-003918:0
- 7,920 shares0Common shares without par valueSEC:0001415889-23-003064:0
- 253 shares@ US$109.0913.4% of flowCommon shares without par valueSEC:0001415889-22-008000:0
- 582 shares@ US$108.650.0000% mcap100.0% of flowCommon shares without par valueSEC:0001415889-22-007183:0
- 10,482 shares0Common shares without par valueSEC:0001415889-22-001746:0
- 5,045 shares0Common shares without par valueSEC:0001415889-21-003516:0
6 of 6 declarations
